Figure 3
From: Serum microRNAs as biomarkers for recurrence in melanoma
Proof-of-principle logistic regression subgroup analysis of stage II patients. (A) ROC curve for the miRNA containing logistic risk model defined for stage II patients had good classification performance (AUC = 0.89). (B) Kaplan-Meier analysis for RFS of high and low recurrence risk groups in stage II patients showed significant separation of RFS curves (p < 0.001 by log rank test)